FDA Classifies Medtronic’s Notification Related To Improper Connection Of Sutureless Intrathecal Catheters As A Class I Recall

Medtronic, Inc. (NYSE: MDT) announced that the U.S. Food and Drug Administration (FDA) has classified its safety alert about the proper connection of sutureless catheters used with implantable drug infusion systems as a Class I recall. The notification relates to the improper connection of its sutureless connector intrathecal catheters (referred to as SC catheters).

More: continued here

Filed under: Medical Devices on September 30th, 2008